Predictive value of intracranial high-density areas in neurological function

Table 1 Clinical characteristics of patients in the non-high-density areas and high-density areas groups, n (%)

	non-HDAs (n = 46)	HDAs (n = 50)	P value
Age (years, mean)	63 ± 10	67 ± 14	0.683
Gender (male)	25 (54)	26 (52)	0.869
Hypertension	20 (43)	23 (46)	0.453
Hyperlipidemia	5 (11)	7 (14)	0.879
Diabetes mellitus	8 (17)	10 (20)	0.648
Heart disease	24 (52)	27 (54)	0.872
Admission NIHSS score (mean)	18 ± 3	19 ± 4	0.047
mRS score < 3	16(35)	31 (62)	0.001

mRS: Modified Rankin Scale; HDAs: High-density areas; NIHSS: National Institutes of Health Stroke Scale.

Table 2 Clinical characteristics of patients in the good prognosis and poor prognosis groups, n (%)

	Good prognosis (n = 49)	Poor prognosis (n = 47)	P value
Age (years, mean)	65 ± 11	67 ± 16	0.878
Gender (male)	26 (53)	25 (53)	0.889
Hypertension	22 (45)	21 (45)	0.552
Hyperlipidemia	6 (12)	6 (13)	0.879
Diabetes mellitus	7 (14)	11 (23)	0.068
Heart disease	26 (53)	25 (53)	0.872
Admission NIHSS score (mean)	17 ± 4	20 ± 3	0.007
HDAs presence	16 (33)	30 (64)	0.004

HDAs: High-density areas; NIHSS: National Institutes of Health Stroke Scale.

Table 3 Self-rating depression scale and self-rating anxiety scale scores of patients in the non-high-density areas and high-density areas groups

	non-HDAs (n = 46)	HDAs (n = 50)	P value
SDS score	58 ± 16	64 ± 13	0.015
SAS score	52 ± 8	59 ± 10	0.032
	Good prognosis (n = 49)	Poor prognosis (n = 47)
SDS score	55 ± 19	65 ± 11	0.021
SAS score	50 ± 8	58 ± 12	0.044

HDAs: High-density areas; SDS: Self-rating depression scale; SAS: Self-rating anxiety scale.